Vertical bone regeneration using rhBMP-2 and VEGF

Abstract

BackgroundSufficient vertical and lateral bone supply and a competent osteogenic healing process are prerequisities for the successful osseointegration of dental implants in the alveolar bone. Several techniques including autologous bone grafts and guided bone regeneration are applied to improve quality and quantity of bone at the implantation site. Depending on the amount of lacking bone one- or two-stage procedures are required. Vertical bone augmentation has proven to be a challenge particularly in terms of bone volume stability. This study focuses on the three dimensional vertical bone generation in a one stage procedure in vivo. Therefore, a collagenous disc-shaped scaffold (ICBM = Insoluble Collagenous Bone Matrix) containing rhBMP-2 (Bone Morphogenetic Protein-2) and/or VEGF (Vascular Endothelial Growth Factor) was applied around the coronal part of a dental implant during insertion. RhBMP-2 and VEGF released directly at the implantation site were assumed to induce the generation of new vertical bone around the implant.MethodsOne hundred eight titanium implants were inserted into the mandible and the tibia of 12 mini pigs. Four experimental groups were formed: Control group, ICBM, ICBM + BMP-2, and ICBM + BMP-2 + VEGF.After 1, 4 and 12 weeks the animals were sacrificed and bone generation was investigated histologically and histomorphometrically.ResultsAfter 12 weeks the combination of ICBM + rhBMP2 + VEGF showed significantly more bone volume density (BVD%), a higher vertical bone gain (VBG) and more vertical bone gain around the implant (PVBG) in comparison to the control group.ConclusionBy using collagenous disc-shaped matrices in combination with rhBMP-2 and VEGF vertical bone can be generated in a one stage procedure without donor site morbidity. The results of the presenting study suggest that the combination of rhBMP-2 and VEGF applied locally by using a collagenous carrier improves vertical bone generation in vivo. Further research is needed to establish whether this technique is applicable in clinical routines.

RETRACTED ARTICLE: Schnurri-3 regulates BMP9-induced osteogenic differentiation and angiogenesis of human amniotic mesenchymal stem cells through Runx2 and VEGF

“…In addition, VEGF is comprehensively expressed by cranial neural crest cells and plays multiple roles in regulating cell proliferation, vascularization, and bone formation, including endochondral ossification as well as intramembranous ossification. In addition, VEGF is widely known to induce angiogenesis 63,64 . In the process of angiogenesis, a variety of factors are involved.…”

Risk factors in bone augmentation procedures

“… Multiple factors influence the expression of bone morphogenetic proteins, including the material used as the carrier, the porosity of the implant surface, and dosage . Bone morphogenetic proteins may also be combined with other growth factors such as beta‐transcription factor proteins (TCP), vascular endothelial growth factor, and platelet‐derived growth factor‐BB to produce new bone formation . The main advantage of bone morphogenetic proteins consists of removing the need to harvest bone from a secondary donor site, thus reducing the potential for comorbidities associated with a secondary harvest .…”

The use of bioactive factors to enhance bone regeneration: A narrative review

“…Finally, the combination of rhBMP‐2 with other growth factors, such as BMP‐7, TGF‐β, PDGF, VEGF and bFGF, has also been suggested to enhance BIC values in canine and minipig circumferential peri‐implant defects (Luo, Zhang, Shi, Cheng & Zhang, ; Meraw, Reeve, Lohse & Sioussat, ; Sun, Wang, Zheng, Fan & Gu, ; Wang, Zheng, Zhao, Liu & Gao, ) and dehiscence‐type defects (Thoma, Cha, Sapata, Jung & Husler, ). In minipigs, enhanced vertical peri‐implant bone regeneration was also shown when adding rhBMP‐2 and VEGF to a disc‐shaped collagenous scaffold (Schorn, Sproll, Ommerborn, Naujoks & Kubler, ).…”